GB2196852B - Novel galenical retard form - Google Patents

Novel galenical retard form

Info

Publication number
GB2196852B
GB2196852B GB8727056A GB8727056A GB2196852B GB 2196852 B GB2196852 B GB 2196852B GB 8727056 A GB8727056 A GB 8727056A GB 8727056 A GB8727056 A GB 8727056A GB 2196852 B GB2196852 B GB 2196852B
Authority
GB
United Kingdom
Prior art keywords
retard
novel galenical
galenical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8727056A
Other versions
GB8727056D0 (en
GB2196852A (en
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz KK
Original Assignee
Sandoz KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE3422083 priority Critical
Priority to DE3442566 priority
Application filed by Sandoz KK filed Critical Sandoz KK
Publication of GB8727056D0 publication Critical patent/GB8727056D0/en
Publication of GB2196852A publication Critical patent/GB2196852A/en
Application granted granted Critical
Publication of GB2196852B publication Critical patent/GB2196852B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
GB8727056A 1984-06-14 1987-11-19 Novel galenical retard form Expired GB2196852B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (3)

Publication Number Publication Date
GB8727056D0 GB8727056D0 (en) 1987-12-23
GB2196852A GB2196852A (en) 1988-05-11
GB2196852B true GB2196852B (en) 1989-05-17

Family

ID=25822108

Family Applications (3)

Application Number Title Priority Date Filing Date
GB8514855A Expired GB2160100B (en) 1984-06-14 1985-06-12 Novel galenical retard form
GB8727055A Expired GB2196851B (en) 1984-06-14 1987-11-19 Novel galenical retard form
GB8727056A Expired GB2196852B (en) 1984-06-14 1987-11-19 Novel galenical retard form

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB8514855A Expired GB2160100B (en) 1984-06-14 1985-06-12 Novel galenical retard form
GB8727055A Expired GB2196851B (en) 1984-06-14 1987-11-19 Novel galenical retard form

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490D0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa Process for the preparation of solid formulations of nifedipine with high bioavailability and prolonged effect and formulations thus obtained
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec pharmaceutical preparation
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
WO2000076480A2 (en) * 1999-06-11 2000-12-21 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
WO2001010466A1 (en) * 1999-08-04 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Stable medicinal compositions for oral use
AU762291B2 (en) 1999-09-30 2003-06-19 Penwest Pharmaceutical Co. Sustained release matrix systems for highly soluble drugs
KR20040058103A (en) * 2001-02-13 2004-07-03 아스트라제네카 아베 Novel Modified Release Formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
AU2007328207A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
RU2483713C2 (en) 2008-08-20 2013-06-10 Борд Оф Риджентс, Зе Юниверсити Оф Техас Систем Extrusion of hot liquid of multiple particles with modified release

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen, De
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-Gmbh, 7850 Loerrach, De
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag Method of analogy for the preparation of 1,4-dihydropyridine derivatives
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag New 1,4-dihydropyridine derivatives, their production and use.
CH642259A5 (en) * 1978-12-21 1984-04-13 Sandoz Ag Galenic preparations for oral application of ergotal caloids.
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (en) * 1981-10-29 1993-02-10 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag TWO-PHASE FORMULATION

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NONE *

Also Published As

Publication number Publication date
ES8702141A1 (en) 1987-01-01
AT391806B (en) 1990-12-10
GB2196852A (en) 1988-05-11
NL8501578A (en) 1986-01-02
BE902626A1 (en)
BE902626A (en) 1985-12-10
IL75490D0 (en) 1985-10-31
NL194389B (en) 2001-11-01
GB8727055D0 (en) 1987-12-23
HK25192A (en) 1992-04-10
GB2196851B (en) 1989-06-07
ES544075D0 (en)
SE8502950L (en) 1985-12-15
SE504583C2 (en) 1997-03-10
DK264785A (en) 1985-12-15
SE8502950D0 (en) 1985-06-13
IT8548210D0 (en) 1985-06-13
FR2565822B1 (en) 1989-02-17
NZ212390A (en) 1992-02-25
IE851460L (en) 1985-12-14
DK264785D0 (en) 1985-06-12
FR2565822A1 (en) 1985-12-20
IE58834B1 (en) 1993-11-17
PT80635A (en) 1985-07-01
ATA174885A (en) 1990-06-15
DE3520184C2 (en) 1997-03-13
HU198844B (en) 1989-12-28
GB2160100B (en) 1989-06-01
HUT40918A (en) 1987-03-30
DK167649B1 (en) 1993-12-06
AU587190B2 (en) 1989-08-10
DE3520184A1 (en) 1985-12-19
CY1635A (en) 1992-11-06
PT80635B (en) 1987-10-20
GB2160100A (en) 1985-12-18
AU4454389A (en) 1990-03-22
GB2196851A (en) 1988-05-11
GB8514855D0 (en) 1985-07-17
AU4348685A (en) 1985-12-19
GB8727056D0 (en) 1987-12-23
NL194389C (en) 2002-03-04
GR851430B (en) 1985-11-25
CA1264441A (en) 1990-01-16
LU85946A1 (en) 1986-01-24
CA1264441A1 (en)
ES544075A0 (en) 1987-01-01
IT1200080B (en) 1989-01-05

Similar Documents

Publication Publication Date Title
AR242476A1 (en) Harvester-thresher
NZ229248A (en) Substituted 2-aminobenzonitriles
GB8529637D0 (en) 13beta-milbemycin derivatives
GB2163150B (en) 3-aminopropoxyaryl derivatives
GB2152033B (en) Sulfonamido-benzamide derivatives
EP0150447A3 (en) Substituted dihydrobenzopyran-2-carboxylates
EP0163324A3 (en) Aminoalkylphenoxy derivatives
GB2155925B (en) Pyrimidylpiperazine derivatives
ZA8502739B (en) 9a-aza-9a-homoerythromycin derivatives
CS301285A2 (en) Tekuty herbicidni prostredek
PT81586A (en) Benzoxazol- and benzothiazolamine derivatives
GB8511530D0 (en) Crane
GB2164644B (en) Benzonorbornene derivatives
DE3565267D1 (en) 9a-aza-9a-homoerythromycin derivatives
GB8514855D0 (en) Galenic retard form
GB8519921D0 (en) Closures
CS647585A2 (en) Pruzna hridelova spojka
GB2162317B (en) Accelerometer
DE3567903D1 (en) Cyclohexane derivatives
CS506885A2 (en) Pohonny agregat
ZA8501870B (en) Nitrification-inhibiting 1-hydroxypyrazole derivatives
GB8519922D0 (en) Closures
CS169785A2 (en) Zpusob vyroby karbamatu celulozy
ZA8507681B (en) Tetrahydronaphtaline derivatives
JPS6166166A (en) Accelerometer

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20050611